Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 2/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | GNAI3 | P08754 | 9/20 | 0.59 |
| ▸ | GNAI1 | P63096 | 9/20 | 0.59 |
| ▸ | GNAO1 | P09471 | 8/20 | 0.53 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.51 |
| ▸ | ATM | Q13315 | 1/20 | 0.48 |
| ▸ | NAAA | Q02083 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9634169 | 1.00 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL23471191 | 0.93 | GNAI3 (0.67) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL9633853 | 0.93 | GNAI3 (0.67) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL23471439 | 0.92 | L3MBTL1 (0.69) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL13290614 | 0.90 | L3MBTL1 (0.85) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL9762648 | 0.88 | L3MBTL1 (0.88) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL9633474 | 0.86 | L3MBTL1 (0.63) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL12141609 | 0.86 | L3MBTL1 (0.60) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| SCHEMBL9761341 | 0.86 | L3MBTL1 (0.92) | L3MBTL1MEN1KMT2ATDP1GNAI3 | |
| N-(Decanoyl)Pyrrolidine SCHEMBL10755236 | 0.84 | L3MBTL1 (0.96) | L3MBTL1MEN1KMT2ATDP1GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2054398-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | Korea Research Institute of Bioscience and Biotechnology (KR) | 2009-05-06 | — | — | EP | disclosed |
| WO-2008018778-A1 | NEW HETEROCYCLIC COMPOUNDS CONTAINING NITROGEN ATOMS OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FOR TREATMENT OF CANCER | KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) | 2008-02-14 | — | — | WO | disclosed |